Phenotype specific identification of prediction factors for exacerbation of asthma and analysis of long-term prognosis -2014 cohort
Not Applicable
Recruiting
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000044099
- Lead Sponsor
- Teikyo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 372
Inclusion Criteria
Not provided
Exclusion Criteria
Patients treated by unapproved drugs for clinical studies. Patients judged as inappropriate for participating to the study by investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time course of annual exacerbation frequency stratified by phenotypes of asthma
- Secondary Outcome Measures
Name Time Method 1. Time course of ACT score, pulmonary function, biomarkers (blood eosinophil counts, total IgE, FeNO) stratified by phenotypes of asthma 2. Prognostic factors for exacerbation frequency and annual decline in FEV1 3. Improvement in exacerbation frequency, ACT sore, and pulmonary function after introduction of biologics in patients treated by antibody therapies